Controlling neuronal pain after shingles

Effect of solution containing Plantago Oata essential oil with a concentration of 5% on controlling neuronal pain after shingles

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151003024317N9

Enrollment

Registered

2020-01-07

Start date

2020-01-20

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zona. Zoster [herpes zoster]

Interventions

Intervention 1: Intervention group: Patients will use Plantago Avata four times a day in the affected areas. Intervention 2: Control group: Patients will take the usual medication four times a day in

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years Post-shingle neuralgia Not taking other medications topically and systemically two weeks before enrollment to study

Exclusion criteria

Exclusion criteria: Wounds or erosion Infection or severe thinning of the affected skin area Mucosal involvement Pregnancy Breastfeeding Mental illness Mental retardation

Design outcomes

Primary

Measure	Time frame
Severity of pain. Timepoint: On arrival - After taking the medicine. Method of measurement: From 1 to 10 (Based on numerical scale).;Severity of drug side effects. Timepoint: After taking the medicine. Method of measurement: From 1 to 4 (Based on numerical scale).;Patient Satisfaction. Timepoint: After taking the medicine. Method of measurement: From 1 to 5 (based on Likert scale).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Rezai

Iran University of Medical Sciences

mah_re@yahoo.com+98 21 6435 2190

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026